Shanghai Kehua Bio-engineering (002022.SZ): Two products obtained medical device registration certificates.
Shanghai Kehua Bio-engineering (002022.SZ) announced that recently, the company and its controlling subsidiary Suzhou Tianlong Biotechnology Co., Ltd. (hereinafter referred to as "Suzhou Tianlong") received medical device registration certificates (in vitro diagnostic reagents) issued by the National Medical Products Administration. The products involved are: "Chlamydia trachomatis nucleic acid detection kit (PCR-fluorescence method)" and "Parainfluenza virus nucleic acid detection kit (fluorescence PCR method)".
Shanghai Kehua Bio-engineering (002022.SZ) announced that recently, the company and its controlling subsidiary Suzhou Tianlong Biotechnology Co., Ltd. (hereinafter referred to as "Suzhou Tianlong") received medical device registration certificates (in vitro diagnostic reagents) issued by the National Medical Products Administration. The products involved are: "Chlamydia trachomatis nucleic acid detection kit (PCR-fluorescence method)" and "Parainfluenza virus nucleic acid detection kit (fluorescence PCR method)".
Related Articles

MEGA GENOMICS (06667) repurchased 96,800 shares on September 15 for approximately HK$690,700.

XIAO NOODLES (02408) repurchased 119,000 shares for HKD 469,500 on September 15.

PURAPHARM (01498) proposes appointing Zhongzheng Tianheng CPA as the new auditor.
MEGA GENOMICS (06667) repurchased 96,800 shares on September 15 for approximately HK$690,700.

XIAO NOODLES (02408) repurchased 119,000 shares for HKD 469,500 on September 15.

PURAPHARM (01498) proposes appointing Zhongzheng Tianheng CPA as the new auditor.

RECOMMEND





